NRG1 and neoplasm: The cutoff values for NRG1 biomarkers-serum NRG1 levels (64.1 ng/mL), NRG1 levels in tumor tissue (143.8 ng/mL), and relative NRG1 mRNA expression in tumor tissue (1.353)-hold important clinical implications for predicting CRPC progression.